| Luz Rodriguez, | |
|
J2-7 Calle 13a, Urb Extencion Rexville, Bayamon, PR 00957-3980 | |
| (787) 210-5885 | |
| Not Available |
| Full Name | Luz Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | J2-7 Calle 13a, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477912251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3026 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Luz Rodriguez, J2-7 Calle 13a, Urb Extencion Rexville, Bayamon, PR 00957-3980 Ph: (787) 210-5885 | Luz Rodriguez, J2-7 Calle 13a, Urb Extencion Rexville, Bayamon, PR 00957-3980 Ph: (787) 210-5885 |
News Archive
The University of Manchester has entered into a new partnership with the US Food and Drug Administration to train new researchers and make advances in drug safety, development and personalised dosage.
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease according to Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer.
​Patients receiving deep brain stimulation are warned that their neurostimulators may dysfunction when confronted by electromagnetic fields that can be generated by particular electrical devices found at work, home, and in the hospital.
While the percentage of obese children in the United States tripled between the early 1970s and the late 2000s, a new study suggests that-at least for middle school students-weight gain has nothing to do with the candy, soda, chips, and other junk food they can purchase at school.
Takeda San Francisco (TSF) and Pieris AG have signed a drug discovery partnership agreement under which Pieris will apply its Anticalin(R) scaffold technology to deliver protein therapeutic candidates to Takeda, both companies announced today. The deal initially will focus on first-in-class drug discovery efforts around a predetermined Takeda target.
› Verified 7 days ago
Jessica L Sepulveda, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Ae14 Calle Rio Humacao, Urb. Rio Hondo 2, Bayamon, PR 00961 Phone: 787-439-8517 | |
Maria De Lourdes Medina, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: T58 Ave Nogal, Lomas Verdes, Bayamon, PR 00956 Phone: 787-405-2933 | |
Melissa Del Rosario Ruiz, MS SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: F34 Calle Guillermina, Urb Flamingo Terrace, Bayamon, PR 00957 Phone: 787-615-1524 | |
Jomarys Ainniz Agosto Cuevas, SPL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Pp14 Calle 5, Bayamon, PR 00957 Phone: 787-998-8866 | |
Mrs. Diana M. Colacioppo-saavedra, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: C/ Vereda Real B-32, Las Veredas, Bayamon, PR 00961 Phone: 787-777-3535 | |
Wernicke Clinical Group Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: Urb. Santa Monica, H-1 Calle 6 Suite 103, Bayamon, PR 00957 Phone: 787-223-7964 | |
Yofrancis Arroyo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Cond Flamingo Apts, Apt 2104, Bayamon, PR 00959 Phone: 787-614-9088 |